Delivery Order SPE2DB22D2007-SPE2DB25FJ1KC

Award Date 5/9/25
Potential Completion Date 6/2/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a ceiling value of $22,175.20. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, with a ceiling value of $11,087.60 and a completion date of May 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $15,517.98, and a period of performance through December 13, 2024. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of PADCEV 30 MG vials. The contract has a completion date of March 14, 2024 and a potential value of $19,999.44. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $46,198.50 and a period of performance through May 20, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,059,447 units of the drug PADCEV 30 MG VIALS, with a ceiling value of $22,175.20 and a period of performance through May 19, 2025. This award is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,719.10, is for the provision of PADCEV 30 MG VIALS, a medical product. The contract has a period of performance that ends on February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 firm fixed-price contract is for the delivery of 4,567,984,057 units of the medication PADCEV 30 MG VIALS. The delivery order, identified as SPE2DX15D1022|SPE2DX25FVEKR, has a performance period through May 12, 2025. This contract is not set-aside and was awarded on April 21, 2025. AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $14,994.18 to AmerisourceBergen Drug Corp for the supply of PADCEV 30 MG VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a firm fixed price...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1KC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG vials, a prescription medication, with a ceiling value of $11,087.60 and a period of performance through June 2, 2025.

The contract is not set aside and is a firm fixed price, delivery order contract type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support various government agencies, including the Defense Health Agency and U.S. Coast Guard, for their military and veteran healthcare programs.

Generated 8/8/25, 10:06 AM